Rice Protein

NEWS: This superfood is now available in the SANEStore as a convenient whole-food powder so you can more easily enjoy it in smoothies and recipes.

Starvation Is NOT Healthy. Stop counting calories & go #SANE w/me at http://SANESolution.com
Starvation Is NOT Healthy. Stop counting calories & go #SANE w/me at http://SANESolution.com

A high-protein alternative to soy and animal products, our natural raw enzyme sprouted Organic Oryzatein Silk Brown Rice Protein Concentrate has a silky smooth texture and higher protein content than other rice protein powders. Our Organic Orzatein Silk has 83% protein content, improved taste and is more easily digested, hypoallergenic and a vegetarian/vegan source of protein. Ideal for those with gastrointestinal sensitivity to milk, wheat, soy and other proteins. Organic Sprouted Brown Rice Protein is gluten-free, vegan and contains no milk, soy, wheat, eggs, corn, yeast, herbs, preservatives, coloring or anything artificial. This protein is made using an all natural process that does not involve the use of chemical solvents.

Sound Promising?

Want to Try Adding a Convenient and Pure Powdered Form of This Whole Food to Your Smoothies and Recipes?

Why Try?

  • 100% Plant-Based Protein
  • Highly Soluble & Easy to Digest
  • Excellent Amino Acid Profile – Especially high in Arginine, Glutamine & Leucine
  • Low Sodium
  • Totally raw with no heat used
  • Non-GMO
  • Bio-fermentation – combining the sprouted endosperm & the bran from raw sprouted whole grain brown rice
  • Hypoallergenic
  • 100% Gluten, Soy, & Cholesterol Free
  • Environmentally Friendly Source of Protein
  • Highly Suitable for Sustainable Agriculture
Starvation Is NOT Healthy. Stop counting calories & go #SANE w/me at http://SANESolution.com
Starvation Is NOT Healthy. Stop counting calories & go #SANE w/me at http://SANESolution.com


1. Anderhuber, R. 1991. Vaccinium myrtillus . Aust J Med Herbalism 3:13–14

2. Azar, M., E. Verette, S. Brun. 1987. Identification of some phenolic compounds in bilberry juice Vaccinium myrtillus. J Food Sci 52(5):1255–1257

3. Barrette, E.P. 1999. Bilberry fruit extract for night vision. Alternative Medicine Alert™ 2(2):20–21

4. Bone, K. and M. Morgan. 1997. Bilberry—The Vision Herb. MediHerb Professional Review 59:1–4

5. Braun, R. et al. 1997. Standardzulassungen für Fertigarzneimittel—Text and Kommentar. Stuttgart: Deutscher Apotheker Verlag.

6. Bravetti, G. 1989. Preventive medical treatment of senile cataract with vitamin E and anthocyanosides: clinical evaluation. Ann Ottalmol Clin Ocul 115:109

7.Bruneton, J. 1995. Pharmacognosy, Phytochemistry, Medicinal Plants. Paris: Lavoisier Publishing

8. Bundesanzeiger (BAnz). 1998. Monographien der Kommission E (Zulassungs- und Aufbereitungskommission am BGA für den humanmed. Bereich, phytotherapeutische Therapierichtung und Stoffgruppe). Köln: Bundesgesundheitsamt (BGA)

9. Caselli, L. 1985. Studio clinico ed elettroretinografico sull’attivita degli antocianosidi [Clinical and electroretinographic study on activity of anthocyanosides]. Arch Med Int (Parma) 37:29–35

10. Cluzel, C., P. Bastide, P. Tronche. 1969. [Phosphoglucomutase and glucose-6-phosphatase activities of the retina and anthocyanoside extracts from Vaccinium myrtillus (study in vitro and in vivo )] [In French]. C R Seances Soc Biol Fil 163(1):147–150

11. Colantuoni, A., S. Bertuglia, M.J. Magistretti, L. Donato. 1991. Effects of Vaccinium myrtillus anthocyanosides on arterial vasomation. Arzneimforsch 41(9):905–909.

12. Cunio, L. 1993. Vaccinium myrtillus . Aust J Med Herbalism 5(4):81–85

13. Deutscher Arzneimittel-Codex (DAC). 1986. Stuttgart: Deutscher Apotheker Verlag

14. Ferretti, C., M.J. Magistretti, A. Robotti, P. Ghi, E. Genazzani. 1988. Vaccinium myrtillus anthocyanosides are inhibitors of cAMP and cGMP phosphodiesterases. Pharm Res Comm 20(11):150

15. Fiorini, G., A. Biancacci, F.M. Graziano. 1965. Modificazioni perimetriche ed adattometriche dopo ingestione di mirtillina associata a beta-carotene [Perimetric and adaptometric modifications after ingestion of myrtillin associated with beta-carotene]. Ann Ottalmol Clin Ocul 91(6):371–386

16. Foster, S. 1996. Bilberry: A Long History. Health Food Business. August 1996: 40

17. Friedrich, V.H. and J. Schönert. 1973. Untersuchungen über einige Inhaltsstoffe der Blätter und Früchte von Vaccinium myrtillus [Phytochemical investigation of leaves and fruits of Vaccinium myrtillus ]. Planta Med 24(1):90–100

18. German Homeopathic Pharmacopoeia (GHP). 1993. Translation of the Deutsches Homöopathisches Arzneibuch (HAB 1), 1st ed., 5th suppl. 1991. Stuttgart: Deutscher Apotheker Verlag. 383–384

19. Ghiringhelli, C., F. Gregoratti, F. Marastoni. 1978. Attivita capillarotrop di antocianosidi and alto dosaggio nella stasi da flebopatia [Capillarotropic activity of anthocyanosides in high doses in phlebopathic statis]. Minerva Cardioangiol 26(4):255–276

20. Grieve, M. 1979. A Modern Herbal. New York: Dover Publications, Inc.

21. Hänsel, R., K. Keller, H. Rimpler, G. Schneider (eds.). 1992–1994. Hagers Handbuch der Pharmazeutischen Praxis, 5th ed. Vol. 4–6. Berlin-Heidelberg: Springer Verlag

22. Jayle, G.E. and L. Aubert. 1964. [Action des glucosides d’anthocyanes sur la vision scotopique et mesopique du sujet normal] [In French]. Therapie 19:171

23. Jayle, G.E. et al. 1965. [Study concerning the action of anthocyanoside extracts of Vaccinium Myrtillus on night vision] [In French]. Ann Ocul (Paris) 198(6):556–562

24. Lagrue, G. et al. 1979. Pathology of the microcirculation in diabetes and alterations of the biosynthesis of intracellular matrix molecules. Front Matrix Biol S Karger 7:324–325

25. Leung, A.Y. and S. Foster. 1996. Encyclopedia of Common Natural Ingredients Used in Food, Drugs, and Cosmetics, 2nd ed. New York: John Wiley & Sons, Inc. 84–85

26. Lietti, A., A. Cristoni, M. Picci. 1976. Studies on Vaccinium myrtillus anthocyanosides. I. Vasoprotective and antiinflammatory activity. Arzneimforsch 26(5):829–832

27. Meyer-Buchtela, E. 1999. Tee-Rezepturen—Ein Handbuch für Apotheker und Ärzte. Stuttgart: Deutscher Apotheker Verlag

28. Morazzoni, P. and E. Bombardelli. 1996. Vaccinium myrtillus L. Fitoterapia 67(1):3–29

29. Neumann, L. 1971. Therapeutische Versuche mit Anthozyanosiden bei Langzeitbehandlungen in der Augenheilkunde [In German]. Klin Monatsbl Augenheilkd 158:592–597

30. Österreichisches Arzneibuch, 1st suppl. (ÖAB). 1983. Wien: Verlag der Österreichischen Staatsdruckerei

31. Österreichisches Arzneibuch (ÖAB). 1991. Wien: Verlag der Österreichischen Staatsdruckerei

32. Pennarola, R. et al. 1980. The therapeutic action of the anthocyanosides in microcirculatory changes due to adhesive-induced polyneuritis. Gazz Med Ital 139:485–491

33. Perossini, M. et al. 1987. Diabetic and hypertensive retinopathy therapy with Vaccinium myrtillus anthocyanosides (Tegens): Double blind placebo controlled clinical trial. Ann Ottalmol Clin Ocul 113:1173

34. Pharmacopoeia Helvetica, 7th ed. Vol. 1–4. (Ph.Helv.VII). 1987. Bern: Office Central Fédéral des Imprimés et du Matériel

35. Pizzorno, J.E. and M.T. Murray. 1992. A Textbook of Natural Medicine. Seattle, WA: Bastyr University Publications

36. Politzer, M. 1977. [Experiences in the medical treatment of progressive myopia] [In German]. Klin Monatsbl Augenheilkd 171(4):616–619

Facebook Comments